Ipca Laboratories approves acquisition of 26.574% of Lyka Labs 

Ipca Laboratories

Ipca Laboratories board has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs Limited and entering into a Joint Management Control Agreement with the Promoters of the said company.

Ipca Laboratories was quoting at Rs 2,058.20, up Rs 1.80, or 0.09 percent on the BSE.

For Enquiry Fill The Form

    *Note:- Please provide a valid Email Id to receive OTP from bigprofitbuzz.com.

    Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button